<DOC>
	<DOCNO>NCT01058824</DOCNO>
	<brief_summary>To assess relative bioavailability two different batch Frademicina® drug product , contain 500 mg lincomycin hydrocloride , manufacture Pfizer Laboratories Ltd . The formulation ' comparative bioavailability oral administration assess base statistical comparison relevant pharmacokinetic parameter , obtain drug concentration blood . The lincomycin hydrocloride concentration measure proper validated analytical method .</brief_summary>
	<brief_title>Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Lincomycin</mesh_term>
	<criteria>Men . Women pregnant nursing . Age 18 50 yearsold . Body mass index ≥ 19 ≤ 28,5 . Good health condition significant disease , judgement legally qualify professional , accord rule define Protocol , base follow assessment : clinical history , pressure pulse measurement , physical psychological examination , ECG complementary laboratorial test . Ability understand nature objective trial , include risk adverse effect , agree cooperate investigator act accord requirement whole assay , confirmed signature Free Informed Consent . Known hypersensitivity study drug ( lincomycin hydrocloride ) compound chemically relate . History presence hepatic , gastrointestinal disease condition may interfere absorption , distribution , excretion metabolism process drug . History hepatic , renal , pulmonary , gastrointestinal , epileptic , hematological psychiatric condition ; hypo hypertension etiology require pharmacological treatment ; history myocardial infarction , angina and/or cardiac insufficiency . Electrocardiographic finding nonrecommended enrollment trial , investigator 's criterion . Results laboratory test normal range , accord standard protocol , unless consider clinically irrelevant investigator . He/She smoker . Drinks 05 cup coffee tea per day . History alcohol drug abuse . Use regular medication within 02 week prior begin treatment assessment date ; use medication within week , except contraceptive medication . Hospitalization reason within 08 week prior begin first treatment period trial assessment date . Treatment within 03 month prior trial drug know toxic potential primary organ . Enrollment experimental trial use experimental drug within 06 month prior begin trial assessment date . Donation loss 450 mL blood within 03 month precede trial donation high 1500 mL within 12 month begin clinical trial assessment date . Consumption induce and/or inhibit enzymatic drug ( CYP450 hepatic ) , toxic organ long halflife period , within 04 week prior begin trial . Consumption alcohol within 48 hour precede enrollment trial clinical trial . Consumption food beverage contain grapefruit 07 day prior trial period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Lincomycin Hydrocloride</keyword>
</DOC>